APA (7th ed.) Citation

N, V., D, S., D, B., L, S., G, B., NJ, E., . . . AVS, H. (2025). R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: An open-label, partially blinded, phase 1-2a controlled human malaria infection study. The Lancet. Microbe, 6(3), 100867. https://doi.org/10.1016/S2666-5247(24)00083-1

Chicago Style (17th ed.) Citation

N, Venkatraman, et al. "R21 in Matrix-M Adjuvant in UK Malaria-naive Adult Men and Non-pregnant Women Aged 18-45 years: An open-label, Partially Blinded, Phase 1-2a Controlled Human Malaria Infection Study." The Lancet. Microbe 6, no. 3 (2025): 100867. https://doi.org/10.1016/S2666-5247(24)00083-1.

MLA (9th ed.) Citation

N, Venkatraman, et al. "R21 in Matrix-M Adjuvant in UK Malaria-naive Adult Men and Non-pregnant Women Aged 18-45 years: An open-label, Partially Blinded, Phase 1-2a Controlled Human Malaria Infection Study." The Lancet. Microbe, vol. 6, no. 3, 2025, p. 100867, https://doi.org/10.1016/S2666-5247(24)00083-1.